Tag: Cancer: Ovarian
Surveillance Feasible for Women Deferring Prophylactic Salpingo-Oophorectomy
Ovarian cancer surveillance has modeled sensitivity and specificity of 87.5 and 99.9 percent and is cost-saving
Frequent Aspirin Use Tied to Lower Ovarian Cancer Risk
Association remains regardless of the presence of most other risk factors for ovarian cancer
Patient-Reported Outcomes + Wearable Data Predict Postop Adverse Events
Findings seen among women with gynecologic cancers followed for four weeks
Trametinib Slows Recurrent Low-Grade Serous Ovarian Carcinoma
Median progression-free survival significantly prolonged with trametinib versus one of five standard-of-care treatment options
Surgery Plus Chemo Better for Treating Relapsed Ovarian Cancer
Overall survival longer with secondary cytoreductive surgery followed by platinum-based chemotherapy versus chemotherapy alone
FDA Approves Imaging Drug That Can Help Surgeons Spot Ovarian Cancers
Drug is designed to improve surgeon's ability to detect ovarian cancer while operating on a patient
Black Women’s Group Sues Johnson & Johnson Over Baby Powder
Lawsuit claims that J&J targeted baby powder ads to Black women despite knowing it contained ingredients that could cause ovarian cancer
Unmet Social Needs, Distress Linked in Gynecologic Oncology Patients
Social isolation and lack of safety at home associated with distress; unmet needs also linked to treatment interruption
Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
Findings seen in BRCA1 and BRCA2 mutation carriers; reduction greater with longer duration of use in BRCA1 carriers
Screening Does Not Reduce Ovarian, Tubal Cancer Deaths
Increase in stage I disease, decrease in stage IV disease incidence seen with multimodal screening versus no screening
